CLINITEST® hCG Test on CLINITEK Analyzers - Rapid and Reliable Pregnancy TestingFebruary 15th, 2018
Study: Exposure to Air affects Integrity of Urine Reagent StripsFebruary 14th, 2018
AACC Annual Scientific Meeting and Clinical Lab Expo
Medlab - The World’s Largest Expo
DubaiBooth No.: Z5 G 42
MEDICA 2017 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
69th AACC Annual Meeting and Clinical Lab Expo - July 30 - August 3, 2017
SAN DIEGO, CA, USA
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
Total Bile Acids (Enzyme Cycling) Test Kit (liquid stable ), R1: 2 x 60 mL R2 :2 x 20 mL
The Diazyme Total Bile Acids assay is a liquid stable system, ready to use for both manual methods and adaptable for many automated chemistry analyzers. The assay has excellent sensitivity with a linear range from 1-180 µmole/L and has been validated for both human and veterinary applications. Diazyme’s unique enzyme cycling method amplifies signal for accurate and fast measurement using a small sample up to 50% less than conventional NBT methods making it an excellent choice for both veterinary and pediatric applications. The assay has excellent precision (%CV <5%) with no significant interference from lipemic or hemolytic samples. Packaged for optimal operator convenience reagent transfer can be eliminated for most chemistry systems with instrument specific packaging options including Roche Hitachi 917 series, Olympus AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The reagent is stable for 12 months from date of manufacture when stored @ 2°-8°C.
Diazyme Total Bile Acids Assay Kit is intended for the in vitro quantitative determination of total bile acids (TBA) in human serum. Total bile acids are metabolized in the liver and serve as a marker for normal and abnormal liver function. Serum total bile acids are increased in patients with liver disease.